OncoSec Medical Operating Income

OncoSec Medical (ONCS) currently reports a operating income of $-33M as of January 2023. That compares with $-44M in the prior-year period — up 25.2% year over year. Use the charts on this page to explore OncoSec Medical's operating income history and peer comparisons.

OncoSec Medical's operating income increased from $-44M to $-33M — a 25.2% year-over-year increase (period ending January 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

OncoSec Medical reported $-33M in operating income as of January 2023. That compares with $-44M in the prior-year period — up 25.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-33M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for OncoSec Medical, and consider following ONCS for alerts when major investors trade the stock.

OncoSec Medical is classified in the Healthcare sector. On operating income, it currently shows $-33M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ONCS with unrelated industries.